News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Paola Alberti: Neuroprotection of Molsidomine against vincristine-induced peripheral neurotoxicity
Photo taken from Paola Alberti/LinkedIn
Aug 25, 2024, 16:46

Paola Alberti: Neuroprotection of Molsidomine against vincristine-induced peripheral neurotoxicity

Paola Alberti, Assistant Professor in Human Anatomy at University of Milano-Bicocca, shared a post on LinkedIn:

“Check out one of the latest publications of our lab in collaboration with Professor Francesco Lotti, Columbia University: Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation.

This joint effort sheds light into possibile neuroprotection strategies against vincristine-induced neurotoxicity.”

‘Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation‘

Authors: Irina Utkina-Sosunova, Alessia Chiorazzi, Mariangels de Planell-Saguer, Hai Li, Cristina Meregalli, Eleonora Pozzi,  Valentina Alda Carozzi, Annalisa Canta, Laura Monza, Paola Alberti, Giulia Fumagalli, Charles Karan, Yalda Moayedi, Serge Przedborski, Guido Cavaletti and Francesco Lotti.

Paola Alberti: Neuroprotection of Molsidomine against vincristine-induced peripheral neurotoxicity

Source: Paola Alberti/LinkedIn

Alessia Chiorazzi Annalisa Canta cancer Charles Karan Columbia University Cristina Meregalli Eleonora Pozzi Francesco Lotti Giulia Fumagalli Guido Cavaletti Hai Li Irina Utkina-Sosunova Laura Monza Mariangels de Planell-Saguer OncoDaily Oncology Paola Alberti Serge Przedborski Valentina Alda Carozzi Yalda Moayedi
Special Coverage
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress
Blog
Dec 21, 2024, 22:33
ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms
Blog
Dec 21, 2024, 22:28
Adekemi Oyewusi: EDUCARE - Supporting the medical treatment and education of those impacted by childhood cancer
Blog
Dec 21, 2024, 22:26
Anas Younes: Transforming outcomes for people living with Blood Cancer
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025
Blog
Dec 21, 2024, 19:19
Registration and abstract submission open for the PTCOG63 - SIOP Europe